Activity-dependent regulation of MHC class I expression in the developing primary visual cortex of the common marmoset monkey by Ribic, Adema et al.
RESEARCH Open Access
Activity-dependent regulation of MHC class I
expression in the developing primary visual
cortex of the common marmoset monkey
Adema Ribic
1,2,6*, Gabriele Flügge
1,5, Christina Schlumbohm
1, Kerstin Mätz-Rensing
3, Lutz Walter
2†,
Eberhard Fuchs
1,4,5†
Abstract
Background: Several recent studies have highlighted the important role of immunity-related molecules in synaptic
plasticity processes in the developing and adult mammalian brains. It has been suggested that neuronal MHCI
(major histocompatibility complex class I) genes play a role in the refinement and pruning of synapses in the
developing visual system. As a fast evolutionary rate may generate distinct properties of molecules in different
mammalian species, we studied the expression of MHCI molecules in a nonhuman primate, the common
marmoset monkey (Callithrix jacchus).
Methods and results: Analysis of expression levels of MHCI molecules in the developing visual cortex of the
common marmoset monkeys revealed a distinct spatio-temporal pattern. High levels of expression were detected
very early in postnatal development, at a stage when synaptogenesis takes place and ocular dominance columns
are formed. To determine whether the expression of MHCI molecules is regulated by retinal activity, animals were
subjected to monocular enucleation. Levels of MHCI heavy chain subunit transcripts in the visual cortex were
found to be elevated in response to monocular enucleation. Furthermore, MHCI heavy chain immunoreactivity
revealed a banded pattern in layer IV of the visual cortex in enucleated animals, which was not observed in control
animals. This pattern of immunoreactivity indicated that higher expression levels were associated with retinal
activity coming from the intact eye.
Conclusions: These data demonstrate that, in the nonhuman primate brain, expression of MHCI molecules is
regulated by neuronal activity. Moreover, this study extends previous findings by suggesting a role for neuronal
MHCI molecules during synaptogenesis in the visual cortex.
Background
The major histocompatibility complex (MHC) is a dense
cluster of genes found in all jawed vertebrates that
encodes a great number of proteins involved in immune
responses [1,2]. A group of these genes, MHC class I,
codes for transmembrane glycoproteins responsible for
presentation of antigenic peptides to cytotoxic CD8+ T
lymphocytes [3]. MHC class I (MHCI) proteins are typi-
cally heterotrimers composed of a polymorphic trans-
membrane heavy chain (HC), a noncovalently attached
ß-2-microglobulin subunit, and a short peptide compris-
ing 8-15 amino acids that is derived from self or foreign
antigens [4,5]. In this form, MHCI modulates immune
response by interacting in trans with a large number of
immune receptors [6]. Additionally, MHCI heavy chains
can be detected under certain conditions on the cell sur-
face without ß-2-microglobulin and peptide [6]. It is
t h o u g h tt h a ti nt h i s“free heavy chain” form, MHCI
molecules may interact in cis with certain receptors and
thereby regulate their trafficking [6-8]. Virtually all
nucleated cells express MHCI proteins, usually in their
heterotrimeric form; however, their expression on neu-
rons was always debated [9]. Despite the controversy,
neuronal expression of MHCI under certain conditions
has been reported [10,11] and recent findings on
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and synaptic plasticity were of great surprise [12-15].
These and other studies begun to unravel the previously
unknown and complicated mechanisms of interactions
between the central nervous and the immune system
that may have great clinical implications [16].
Although MHCI genes are well conserved among
mammals, there are a number of differences in the orga-
nization, structure, and function of these genes between
rodents and primates, including humans [17]. The first
study on the function of MHCI molecules in the central
nervous system (CNS) proposed a role for them in the
removal of excess synapses in the developing visual sys-
tem [15]. The visual system displays two forms of plasti-
city: visual input-driven, activity-dependent plasticity
and activity-independent plasticity [18]. The develop-
ment of the main structures of the visual system, the
thalamus and the primary visual cortex (V1), are at least
at certain developmental stages dependent on the activ-
ity coming from the retina [19,20]. The thalamic dorso-
lateral geniculate nucleus (LGN) is the first relay
structure of visual input and is organized into segre-
gated, eye-specific neuronal layers that form upon sti-
mulation by early spontaneous activity of retinal
ganglion cells [19]. Neurons of the LGN send their pro-
jections to V1 where their activity is needed in proper
development of eye-specific populations of neurons
assembled in the ocular dominance columns (ODCs;
[18]). Blockade of activity of one eye during develop-
ment of the visual circuits while leaving the other one
intact (monocular deprivation) perturbs the segregation
of the LGN neurons into eye-specific layers [19,21]. In
V1, as a consequence of visual deprivation, the popula-
tion of neurons responsive to the intact eye increases
[18,22]. Monocular deprivation by means of tetrodo-
toxin-induced block of retinal activity downregulates
MHCI expression levels in the LGN [15]. Furthermore,
it was reported that MHCI molecules are indispensable
for developmental refinement in the LGN, i.e. for
removal of excess synapses during normal development
[12,23]. Asides from differences in the structure and
function of MHCI genes, primates and rodents differ
significantly in terms of structure of their visual systems
[24]. To gain an insight into the role of MHCI molecules
in the nonhuman primate brain, we investigated the spa-
tiotemporal pattern of expression of MHCI genes in the
primary visual cortex of the common marmoset monkey.
Our data confirmed that MHCI molecules are expressed
in the developing visual cortex of the marmoset monkey
and that their levels are regulated by neuronal activity.
However, the temporal pattern of their expression during
development of the V1 and their expression levels upon
monocular enucleation indicated that MHCI molecules
investigated here may not be involved in synapse
elimination, but rather in synaptogenesis. These results
not only validate the potentially important role of neuro-
nal MHCI molecules in visual cortex development, but
also point to interesting interspecies differences in their
distribution, and potentially their function.
Methods
Animals
Thirty-six common male marmoset monkeys (Callithrix
jacchus) were investigated. The animals were obtained
from the breeding colony at the German Primate Center
(Göttingen, Germany). All investigations and the experi-
ments were performed to the highest ethical standards
according to the relevant local, national and interna-
tional regulations concerning the use of animals. All
research projects were carried out only with authoriza-
tion from the relevant ethics committees. We employed
the minimum number of animals required to obtain
consistent data and to avoid animal suffering. For the
termination of non-human primates, the legal require-
ments, guidelines and recommendations set by the
national authorities were followed strictly. The use of
animals including non-human primates in research in
Germany is based on the “Tierschutzgesetz” (Animal
Protection Law) of the 25
th of May, 1998 (BGBl.I Nr.30
v.29.5.1998, S. 1105) and the EU guidelines 86/609/EEG.
The proposals for research conducted in this study are
approved by the local Government and a specially
appointed Ethical Review Committee (Niedersächsisches
Landesamt für Verbraucherschutz und Lebensmittelsi-
cherheit, permit numbers 33.11.425-04-003/08 and
33.11.425-04-026/07).
For expression studies, animals of the following ages
were used [25,26]: postnatal days 1 and 7, and postnatal
months 1, 3, 5, 7, 12, and 21 (N = 3 per age). For mono-
cular enucleation (ME), the left eyes of one month-old
marmoset monkeys (N = 6; approximate body weight
75 g) were surgically enucleated under general anesthe-
sia. As anesthesia, the animals received 0.1 ml of a pre-
mix containing 4 mg/ml alphaxalon and 1.33 mg/ml
alphadolon (Saffan
®; Schering-Plough Animal Health,
Welwyn Garden City, UK), 0.37 mg/ml diazepam, and
0.015 mg/ml glycopyrroniumbromid (Robinul
®; Riemser,
Germany). Enucleation was carried out as described for
pet animals [27] and the eyehole was filled with Gelas-
typt
® sponge (Sanofi-Aventis, Frankfurt, Germany) as
soon as arterial bleeding was no longer visible. The
wound was closed with an intracutane suture of vicryl
6-0 (V302H; Ethicon, Norderstedt, Germany). Directly
after surgery (day 0) and at days 3 and 5, all animals
received an antibiotic (amoxicillin-trihydrate; Duphamox
LA
®, Fort Dodge, Würselen, Germany). ME animals and
six age-matched controls were sacrificed at five months
of age [28].
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For in situ hybridization, brains were immediately
removed from terminally anesthetized animals [overdose
of ketamine (50 mg/ml), xylazine (10 mg/ml), and atro-
pine (0.1 mg/ml)] and the whole visual cortices were
quickly dissected (area determined according to [29,30]),
embedded in Tissue Tek (Sakura Finetek, Heppenheim,
Germany), flash frozen in liquid nitrogen, and stored at
-80°C. Frozen brains were sectioned using a cryostat
(Leica CM3050, Bensheim, Germany) and coronal sec-
tions (10 μm) of whole visual cortices were thaw-
mounted on adhesive silane-coated slides (Histobond,
Marienfeld, Laboratory Glassware, Lauda-Königshofen,
Germany). For immunohistochemistry, marmosets that
were terminally anesthetized (see above), were perfused
transcardially with 0.9% saline, followed by 200 ml of
fixative containing 4% paraformaldehyde in 0.1 M
sodium-phosphate buffer (pH 7.2) for 15 min. The
heads were postfixed in the same fixative, and brains
were carefully removed from the skulls on the following
day. After cryoprotection in 0.1 M phosphate-buffered
saline (PBS; 0.1 mM phosphate buffer, 0.9% NaCl, pH
7.2) containing 30% sucrose, serial coronal sections of
t h ee n t i r ev i s u a lc o r t i c e s( t h i c k n e s s :4 0μmf o re x p r e s -
sion studies and 60 μm for ME animals and controls)
were obtained using a cryostat.
PCR cloning of MHCI transcripts
The isolation of the common marmoset MHC class I
heavy chain cDNA sequences was carried out using
reverse transcriptase polymerase chain reaction (RT-
PCR). One microgram of total brain RNA was reverse
transcribed using the oligo (dT) primer and 400 U of
reverse transcriptase (Promega, Mannheim, Germany).
An aliquot of this reaction was used as a template in a
PCR containing primers designed with the Primer3 soft-
ware [31]. Primers were devised to amplify full-length
marmoset MHC class I heavy chain transcripts (acces-
sion number: U59637). Primer sequences also included
BamHI restriction sites and were as follows: forward 5’-
CACGGATCCCACTTTACAAGCCGTGAGAGAC-3’,
reverse 5’-CACGGATCCCTCCTGTTGCTCTCGGG
GGCCTTG-3’. Caja-G*1 (accession number: U59637)
was obtained and cloned into the pDrive vector
(Qiagen).
In situ hybridization
Cryosections (10 μm) of visual cortices were dried at RT
for 20 min, fixed in 4% buffered paraformaldehyde
(PFA, pH 7.2), rinsed in PBS, acetylated (0.1 M trietha-
nolamine, 0.25% acetic acid anhydride), washed in PBS,
and dehydrated through a graded ethanol series. Caja-G
plasmid DNA was linearized and riboprobes were
synthesized using T7 and SP6 RNA polymerases
(Promega, Madison, WI, USA) for the antisense and
sense probe, respectively, in the presence of 9.25 MBq
of
33P-UTP (Hartmann Analytic GmbH, Braunschweig,
Germany; specific activity, 3,000 Ci/mmol) for 1 h at
37°C. Probes were purified using Microspin S-400 HR
columns (Amersham Pharmacia, Freiburg, Germany)
and hybridization buffer (50% deionized formamide, 10%
dextran sulphate, 0.3 M NaCl, 1 mM EDTA, 10 mM
Tris-HCl, pH 8.0, 500 μg/ml tRNA, 0.1 M dithiothreitol,
and 1 × Denhardt’ss o l u t i o n )w a sa d d e dt oy i e l daf i n a l
probe activity of 5 × 10
4 cpm. The hybridization mix-
ture containing the probe was denatured at 70°C for
10 min, cooled to 55°C, and pipetted directly onto sec-
tions (80 μl/section). Hybridization was performed for
18 h at 68°C. Sections were subsequently washed in 4 ×
SSC (0.6 M NaCl, 0.06 M citric acid), 2 × SSC, and 0.5
× SSC for 10 min each at 37°C. After incubation (1 h at
75°C) in 0.2 × SSC, sections were washed twice in 0.1 ×
SSC, once at 37°C and again at RT, for 10 min each.
Finally, sections were dehydrated through graded alco-
hols, air dried, and exposed to Bio-Max MR film (Amer-
sham Pharmacia) for three days at 4°C. Films were
developed and fixed with GBX (Kodak, Rochester, NJ,
USA).
Quantitative in situ hybridization
After in situ hybridization, sections were coated with
photoemulsion (Kodak NBT2, Rochester, NJ, USA) at
42°C, dried for 90 min at RT, and stored for seven
weeks at 4°C in a lightproof container. Exposed slides
were developed at 15°C for 5 min (Kodak developer D-
19), rinsed twice briefly in H2O, and fixed for 5 min at
RT (fixer, Kodak Polymax). Sections were counter-
stained either with 0.05% toluidine blue in 0.1% diso-
dium tetraborate (Sigma) for expression studies or with
methyl green (Sigma) for monocular enucleation studies,
cleared in xylol, and coverslipped using mounting med-
ium (Eukitt, Kindler, Freiburg, Germany). Hybridized
sections were visualized with a 40× objective (NA = 1.4;
Zeiss) under a light microscope (Axioscope, Zeiss) and
silver grain quantification was performed on a cell-by-
cell basis using ImageJ (U.S. National Institutes of
Health, Bethesda, Maryland, USA). Images were
obtained from layer IV neurons and, for each area
within the primary visual cortex (demarcated according
to [29,30]) two images were acquired, i.e., one using a
green filter to eliminate background staining from
methyl green and one using white light to later precisely
localize neuronal nuclei. A circular counting mask of
15 μm in diameter was used to delineate the region of
interest and was placed over neuronal nuclei during
counting. Relative optical density (ROD) threshold
intensities were optimized to detect exposed silver
grains exclusively. The silver grain density within the
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pared between layer IV neurons in primary visual cor-
tices of six animals (three slides per animal, minimum
300 neurons per animal were counted) using Student’st
test (GraphPad Prism version 4 for Windows, GraphPad
Software, San Diego, CA, USA).
Quantitative RT-PCR
To isolate RNA for RT-PCR, brains were immediately
removed from terminally anesthetized animals (see
above) and whole occipital lobes containing visual cor-
tices were quickly dissected. Total RNA was isolated
from both hemispheres of dissected tissue samples from
animals at the age of five months (N = 3 controls and N
= 3 unilaterally enucleated animals) using the QIAGEN
RNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. As the cortices had to be
separated during RNA isolation due to their size, both
left and right hemispheres of all animals were treated as
independent samples. The integrity and quantity of puri-
fied RNA was assessed by spectrophotometry. Comple-
mentary DNA (cDNA) was synthesized from mRNA
transcripts using oligo (dT)12-18 primers and Superscript
II reverse transcriptase (Invitrogen, Karlsruhe, Ger-
many), according to the manufacturer’s instructions.
The Primer3 software v2.0 [31] was used to design
gene-specific primers, with amplicons ranging from 50
to 150 bp in length. The primers used for the detection
of MHC class I heavy chain transcripts were: forward 5’-
GTGATGTGGAGGAAGAACAGC-3’, reverse 5’-CACT
TTACAAGCCGTGAGAGA-3’ (CajaG*01, accession
number U59637). Primers for the detection of GFAP
were: forward 5’-AAACGAGTCCCTGGAGAG-3’,
reverse 5’-TCCTGGTACTCCTGCAAGT-3’ (marmoset
GFAP, Ensembl transcript number ENSCJAT00
000024380). Primers for the detection of c-Fos were:
forward 5’-CGAAGGGAAAGGAATAAGAT-3’, reverse
5’-GCAGACTTCTCATCTTCCAG-3’ (marmoset c-Fos,
Ensembl transcript number ENSCJAT00000040535). Pri-
mers for the detection of b-actin were: forward 5’-
CATCCGCAAAGACCTGTATG-3’, reverse 5’-GGAG-
CAATGACCTTGATCTTC-3’ (marmoset ß-actin, acces-
sion number DD279463). A quantitative analysis of gene
expression was performed using the 7500 Real-time
PCR apparatus (Applied Biosystems, Darmstadt, Ger-
many) in combination with Quantitect SYBR green
technology (Qiagen). The light cycler was programmed
to the following conditions: an initial PCR activation
step of 10 min at 95°C, followed by 40 cycling steps
(denaturation for 15 s at 95°C, annealing for 30 s at 55°
C, and elongation for 60 s at 72°C). Details of the quan-
titative real-time PCR were described previously [32].
Dissociation curves were generated for all PCR products
to confirm that SYBR green emission was detected from
as i n g l eP C Rp r o d u c t[ 3 3 ] .A l lp r o d u c t sw e r er u no n
2.5% agarose gels to confirm a single product (Addi-
tional file 1). The Caja-G PCR product was additionally
sequenced using the BigDye Terminator Sequencing Kit
(Applied Biosystems) and forward primer in order to
confirm its identity (Additional File 2). The relative
abundance of the MHCI-HC, c-Fos and GFAP mRNA
transcripts was calculated relative to the mRNA levels of
the internal reference gene b-actin and was compared
between both left and right cortices of control and enu-
cleated animals using Student’s t-test (GraphPad Prism
version 4 for Windows).
Immunocytochemistry for light microscopy
Coronal cryosections (40 μm for expression studies and
60 μm for ME animals) of occipital lobes were collected
and washed briefly in PBS before the epitope retrieval
step. Epitope retrieval was performed by incubating the
sections for 20 min in 10 mM sodium citrate buffer pre-
heated to 80°C. Sections were later brought to RT,
washed in PBS, and quenched of endogenous peroxidase
activity using 30 min incubation at RT in 0.5% H2O2 in
distilled water. Sections were then washed in PBS,
blocked for 1 h at RT (3% normal horse serum in PBS),
incubated for 16 h at 4°C with mouse monoclonal
TP25.99 or Q1/28 IgG [34,35] kindly provided by S.
Ferrone, University of Pittsburgh, USA), 1:300 dilution
in 3% normal horse serum in PBS; monoclonal mouse
W6/32 [36], 1:300 dilution in 3% normal horse serum in
PBS; monoclonal rabbit anti c-Fos (Cell Signalling Tech-
nologies, Beverly, MA, USA); monoclonal anti-GFAP
(Sigma) 1:200 dilution in 0.01% Triton-X 100 and 3%
normal horse serum in PBS; or control mouse IgG
(Sigma), and washed again. For c-Fos, W6/32 and GFAP
staining, the epitope retrieval step was not performed.
Sections were then incubated with biotinylated horse
anti-mouse IgG or donkey anti-rabbit IgG (Vector
Laboratories, Burlingame, CA, USA), 1:200 dilution in
3% normal horse serum in PBS, for 1 h at RT. After
washing, sections were incubated with avidin-biotin
horseradish peroxidase (Vectastain Elite ABC Kit, Vector
Laboratories, Burlingame, CA, USA), 1:100 dilution in
3% normal horse serum in PBS, for 1 h at RT, washed
in PBS and then again in 0.05 M Tris/HCl (pH 7.2)
prior to DAB detection (DAB detection with or without
nickel enhancement was performed according to the
manufacturer’s instructions; DAB-Kit, Vector Labora-
tories). Sections were washed in 0.05 M Tris/HCl (pH
7.6) and again in 0.1 M PBS prior to xylol clearance,
dehydration, and coverslipping with Eukitt mounting
medium (Kindler). For identification of cortical layers,
sections adjacent to the ones used for immunocyto-
chemistry were stained with toluidine-blue (Sigma).
Digital images of stained sections were acquired using
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assembled in Corel PhotoPaint X3 and, in case of higher
magnifications, were a composition of 4-5 images along
the longitudinal axis of the primary visual cortex
[29,30]. Contrast and luminosity were adjusted in Corel
PhotoPaint X3 for images obtained from monocularly
enucleated animals.
Immunofluorescence and confocal microscopy
Antibodies used in double-labeling experiments were
applied sequentially and blocking steps were performed
using normal sera of the host species from which the
respective secondary antibodies were derived. Cryostat
sections (40 μm) of occipital lobes were rinsed in PBS
before the epitope retrieval step was performed, as
described above. Nonspecific antibody binding sites
were blocked with 3% normal serum in PBS for 1 h at
RT. Sections were then incubated with mouse monoclo-
nal TP25.99 antibody, 1:300 in 3% normal serum in
PBS, for 16 hrs at 4°C, washed, and incubated in sec-
ondary antiserum (Alexa 488-coupled goat anti-mouse,
Molecular Probes, Invitrogen, Leiden, Netherlands) at a
dilution of 1:500 for 4 h in a lightproof container. Sec-
tions were then washed and incubated with either rabbit
anti-MAP2 antibody (1:200, Synaptic Systems, Göttin-
gen, Germany), rabbit anti-NMDAR1 (1;200, Synaptic
Systems), rabbit anti-GFAP (1:500, Synaptic Systems), or
rabbit anti-vimentin antibody (1:200, Synaptic Systems)
in 3% normal serum in PBS for 16 h at 4°C. For GFAP-
vimentin colocalization studies, the epitope retrieval step
was not performed and following primary antibodies
were used: rabbit anti-vimentin (1:200, Synaptic Sys-
tems) and mouse anti-GFAP (1:200, Sigma). Sections
were then washed and incubated 4 h at RT in secondary
antiserum (Alexa 568-coupled goat anti-rabbit, Molecu-
lar Probes, Invitrogen) diluted 1:500 in 3% normal
serum in PBS. Thereafter, sections were washed in PBS
and floated/mounted on SuperFrost
®Plus slides (Men-
zel-Gläser GmbH, Braunschweig, Germany) in distilled
water, allowed to dry overnight at 4°C, and coverslipped
with mounting medium (Aqua-Polymount, Polysciences
Inc., Warrington, PA, USA). For control sections, the
same procedures were performed omitting the primary
antibody.
Confocal microscopy was performed using a laser-
scanning microscope (LSM 5 Pascal, Zeiss) with an
argon 488 nm laser and a helium/neon 543 nm laser (in
multiple-tracking mode). High magnification, single
optical plane images of layer IV neurons of the primary
visual cortex [29,30] or of the subcortical white matter
in the occipital lobes were obtained at a resolution of
1,024 × 1,024 with an Apochromat 63× oil objective
(NA = 1.4) and immersion oil (Immersol, Zeiss; refrac-
tive index = 1.518). The control sections (no primary
antibodies) displayed only background fluorescence
(data not shown).
Protein extraction
Brains were immediately removed from terminally
anesthetized animals (see above), and the whole visual
cortices were quickly dissected. Whole visual cortex
samples were homogenized with a Dounce homogenizer
(tight pestle) in ice-cold homogenization buffer consist-
ing of 50 mM Tris/HCl pH 7.4, 7.5% glycerol, 150 mM
NaCl, 1 mM EDTA, 1% Triton-X 100, and complete
protease inhibitor cocktail (Roche Diagnostics, Man-
nheim, Germany). After homogenization, the samples
were centrifuged at 4,000× g for 20 min at 4°C. The
resulting supernatant was centrifuged again until it was
clear. Protein concentration was measured using the
Bio-Rad DC Protein assay (Bio-Rad Laboratories, Her-
cules, CA, USA).
Immunoblot analysis
Protein preparations were electrophoresed in 12.5%
SDS gels under reducing conditions. Proteins were
subsequently transferred to nitrocellulose membranes
(Schleicher and Schuell, Dassel, Germany) via semidry
electroblotting for 2 h at 1 mA/cm
2 in transfer buffer
containing 25 mM Tris-base, 150 mM glycine, and
10% (v/v) methanol. After the transfer, the blotted
membranes were blocked with 5% (w/v) milk powder
and 0.1% Tween-20 in PBS for 1 h at RT and were
then incubated with either monoclonal TP25.99
(1:1,000) or monoclonal anti-SNAP-25 (1:1,000, Synap-
tic Systems) antibodies overnight at 4°C. After washing
three times for 5 min in PBS/0.1% Tween-20, blots
were incubated for 1 h at RT with horseradish peroxi-
dase-coupled goat anti-mouse IgG (1:4,000, Santa Cruz
Biotechnology, Santa Cruz, USA). Prior to visualiza-
tion, blots were washed in PBS/0.1% Tween-20 (3 ×
5 min) and once more in PBS. Signals were visualized
using SuperSignal West Dura enhanced luminescence
substrate (Pierce Biotechnology, Rockford, IL, USA).
Membranes were subsequently stripped in a mixture of
b-mercaptoethanol and SDS in PBS and incubated
with monoclonal anti-b-actin antibody (1:4000, Sigma).
For controls, the same procedures were performed
using the mouse IgG (Sigma) instead of a primary anti-
body. Control IgG yielded no signals in the Western
blot (data not shown). For quantification, blots were
visualized with MCID Basic software (Imaging
Research Inc., St. Catherines, Ontario, Canada) so that
nonsaturating bands were obtained. Quantification was
performed using the gel analysis plug-in of ImageJ
(U.S. National Institutes of Health, Bethesda, Mary-
land, USA). Values obtained for MHCI and SNAP-25
were normalized to ß-actin values.
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animals
Digital images of immunostained tissue sections were
acquired using an Axiophot II microscope (Zeiss).
Images were taken from the V1 areas of right visual cor-
tices. Variations in MHCI immunoreactivity through
layer IV were measured as described previously [37].
Briefly, images were normalized and black-white
inverted using ImageJ (U.S. National Institutes of
Health, Bethesda, MD, USA) and regions within layer IV
that encompassed the thickness of the entire layer IV
(2 mm in length and approximately 1 mm in thickness)
were defined as the regions of interest. For identification
of cortical layers, sections adjacent to the ones used for
immunocytochemistry were stained with toluidine-blue
(Sigma). The density profile of layer IV in the primary
visual cortex (region demarcated according to [29,30])
was obtained using ImageJ. Values were averaged (using
the four closest neighbors) and plotted as a function of
the distance along layer IV parallel to the pia mater.
After delineating the borders of immunoreactive
patches, their width was measured using ImageJ and
compared using Student’s t-test (GraphPad Prism ver-
sion 4 for Windows).
Results
Expression of MHCI molecules in LGN and V1 of the
common marmoset
To investigate the expression of MHCI genes in the
marmoset LGN and primary visual cortex, a full-length
clone of the heavy chain (HC) of the classical marmoset
MHCI gene Caja-G [accession number U59637 [38])
was used for in situ hybridization experiments. Animals
were chosen based on age and according to the main
stages of visual system development [25,26] and were of
the following ages: postnatal days 1 and 7; and postnatal
months 1, 3, 5, 7, 12, and 21. Although LGN develop-
ment occurs in utero in primates [39,40], we expected
to observe strong expression of MHCI-HC (MHCI
heavy chain) in newborn animals, as the expression of
these genes persists in the LGN of adult rodents and
c a t s[ 1 2 , 1 5 ] .T oo u rs u r p r i s e ,t h e r ew a sa l m o s tn o
MHCI-HC signal in the marmoset LGN, even after long
exposures to autoradiographic films (Figure 1). However,
in situ hybridization revealed a strong expression of
MHCI-HC throughout the visual cortex. On postnatal
day 7, this expression was mainly concentrated in layers
I and IV of both primary and secondary visual cortex
[V1 and V2, Figure 2A; regions demarcated according to
[29,30]) and in the subcortical white matter (Figure 2A
and 2B). In older animals (1 to 7 months of age), the
signal became more diffuse, with cells in all cortical
layers exhibiting MHCI-HC gene expression (Figure 2A
and 2B). This pattern of MHCI-HC mRNA expression
remained the same throughout postnatal months 12 and
21 (data not shown). Emulsion autoradiography revealed
the presence of silver grains clustered over single cells
in layer IV of the primary visual cortex (Figure 2B).
However, with this technique, the number of labeled
cells appeared relatively low because the liquid photo
emulsion that is used for dipping the radiolabeled sec-
tions is less sensitive to the radioactivity than the auto-
radiographic films. The sense probe was used as a
control and it yielded no signal, thus demonstrating the
specificity of the MHCI-HC antisense probe (Figure 2A
and 2B).
Antibodies against marmoset MHCI proteins are not
available; however, because of the high similarity of
these proteins with their human homologues, we used
the well characterized TP25.99 antibody for the detec-
tion of marmoset MHCI proteins [34,35]. The epitope
to which this antibody binds is situated in the a-3
domain of MHCI molecules, which is monomorphic
and the most conserved domain across all species [34].
This domain is almost identical between marmosets and
humans. Moreover, the TP25.99 antibody is also one of
t h ea n t i b o d i e st h a tr e c o g n i z et h ef r e eh e a v yc h a i nf o r m
of MHCI [41,42]. TP25.99 recognized a band of
approximately 45 kDa on Western blots, which is the
Figure 1 Lack of MHCI-HC expression in the lateral geniculate
nucleus as revealed by in situ hybridization. Autoradiograph of a
brain section of a 7 days-old marmoset from the level of the lateral
geniculate nucleus (LGN) processed for in situ hybridization (left)
and toluidine-blue stained section (right). Note the absence of
MHCI-HC signals in the LGN (delineated with arrowheads).
Abbreviations: Dentate gyrus, DG; postnatal day, PD. Scale bar:
1 mm.
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Page 6 of 18Figure 2 Expression of MHCI-HC in the primary visual cortex as revealed by in situ hybridization. A) Autoradiographs of visual cortices
processed for in situ hybridization. Sections represent the main stages of visual cortex development. The expression of MHCI-HC in the 7
days-old animal (PD7) decreases with progressing age (compare with 7 months-old animal, PM7). Primary visual cortex (V1) is delineated with
white dashed lines. Layer IV and subcortical white matter are delineated with white lines. Abbreviations: Postnatal day, PD; postnatal month, PM;
primary visual cortex, V1; secondary/prestriate visual cortex, V2; subcortical white matter, SWM; layer IV, IV. Scale bar: 1 mm. B) Upper row:
Toluidine-blue stained section of a 7 days-old animal (left) after in situ hybridization, and autoradiograph of the same section (middle panel; film
autoradiography) reveal MHCI-HC signals in layers I and IV-VI of the primary visual cortex and in the subcortical white matter (SWM). Emulsion
autoradiography (right) reveals silver grains clustered over single cells (arrowheads). Middle row: Toluidine-blue stained section of a 1-month old
animal (left) after in situ hybridization and autoradiograph of the same section (middle panel) revealed MHCI-HC signals in all cortical layers and
in the subcortical white matter (SWM). Emulsion autoradiography (right) reveals silver grains clustered over single neurons (arrowheads). Bottom
row: Sense probe revealed only background signals (left; film autoradiograph) and background levels of silver grains in emulsion
autoradiography (right). Roman numerals denote cortical layers. Scale bar for film autoradiographs: 1 mm. Scale bar for emulsion
autoradiography: 20 μm. Abbreviations: Postnatal day, PD; postnatal month, PM; primary visual cortex, V1; subcortical white matter, SWM.
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3A). Protein expression was quantified in animals aged
one, three, and five months, which represent the main
stages of synaptogenesis, namely the initial, the peak
and the refinement stage [26]. MHCI-HC protein levels
at these stages coincided with levels of the synaptogen-
esis marker SNAP-25 (Figure 3B and [43]). Immunocy-
tochemistry revealed a strong MHCI-HC staining of
neurons throughout the primary visual cortex of a 7
months-old animal (Figure 4) and the same staining pat-
tern was observed in all developmental stages (data not
shown).
To further demonstrate that MHCI-HC protein
expression in the primary visual cortex is neuronal, we
performed double-labeling experiments using TP25.99
and an antibody against microtubule associated protein
2 (MAP2), which is an established dendritic marker
[44-46]. A punctuate pattern of MHCI-HC immunor-
eactivity that colocalized with MAP2-positive neuronal
processes was observed in the neuronal somata, den-
drites and neuropil in the main thalamorecipient layer
of V1, layer IV (Figure 5). As previously reported [23],
MHCI-HC protein partially colocalized with both
gephyrin and SAP102, markers of inhibitory and excita-
tory synapses respectively ([47-50]; Additional file 3). In
situ hybridization also showed strong MHCI-HC gene
expression in the subcortical white matter in the occipi-
tal lobes, consistent with previous studies on MHCI in
the visual cortex of cats [15]. This region contains spe-
cialized glial cells, radial glia, involved in neuronal
differentiation and migration [51]. Double-labeling
experiments using antibodies against MHCI-HC and
vimentin, a marker of radial glia [52,53] confirmed that
MHCI-HC is indeed expressed on radial glia in the sub-
cortical white matter (Figure 6). Vimentin-positive cells
also displayed strong immunoreactivity for GFAP (glial
fibrillary acidic protein) in the subcortical white matter
([54]; Additional file 4), but vimentin immunoreactivity
could only be detected in this region. No vimentin-posi-
tive cells and only GFAP immunoreactivity was detected
in the visual cortex (Additional file 4). The MHCI-HC
Figure 3 MHCI-HC protein levels at different stages of visual
cortex development. The antibody TP25.99 (mouse anti-human
MHCI) recognized bands of appropriate size for MHCI-HC protein
(MHCI-HC, A) in Western blots of proteins extracted from the
marmoset visual cortex. Animals were 1, 3 and 5 months old (PM1,
3, 5) representing the main stages of synaptogenesis: initial stage,
peak and rapid decline/synaptic refinement, respectively. SNAP-25
was used as a marker of synatogenesis. Data were normalized to ß-
actin. Molecular weights (in kDa) are indicated on the left side. Data
are from three independent experiments with N = 1 animal per
stage (B).
Figure 4 MHCI-HC immunoreactivity in the primary visual
cortex of the common marmoset. Representative coronal section
of the primary visual cortex of a 7 months-old marmoset probed
with TP25.99 antibody (mouse anti-human MHCI) revealing strong
staining of neurons in all layers (left). Roman numerals denote
cortical layers. Control mouse IgG showed no reaction (right). Scale
bar: 200 μm. Abbreviations: Postnatal month, PM; subcortical white
matter, SWM; primary visual cortex, V1.
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astrocytes (Additional file 4). However, fully assembled
heterotrimeric MHCI molecules could be detected on
microglial cells in the cortex with W6/32 antibody
(Additional file 5). W6/32 is a prototypic anti-MHC
class I antibody that binds to a conformational epitope
on MHCI heavy chains upon their association with b-2-
microglubulin and the peptide [36,41,55]. Interestingly,
another antibody that recognizes free heavy chains,
monoclonal Q1/28 [34] recognized neuronal-like pro-
cesses and cell bodies in the marmoset cortex (Addi-
tional file 5). This, along with our previous studies
[56,57], further suggested that neurons might express
MHC class I molecules preferentially in their free heavy
chain form on the cell surface. Unfortunately, we could
not reliably detect ß-2-microglobulin subunit with the
antibodies available to us (data not shown), although we
have detected ß-2-microglobulin transcripts in the mar-
moset cortex in our previous study [56].
Expression levels of MHCI molecules are regulated by
neuronal activity
Several previous studies suggested a variety of nonim-
mune roles for MHCI molecules, most of which refer to
Figure 5 MHCI-HC protein colocalizes with the neuronal marker MAP-2 in layer IV neurons of the V1. MHCI-HC (green; A) is localized
mainly to the neuronal somata in the primary visual cortex, where it colocalizes with MAP-2 (red; B and C). Higher magnification of the area
indicated by the dashed line in C reveals MHCI clustered over MAP2-positive neurons and processes (arrowheads; D). Scale bar in C: 50 μm; scale
bar in D: 25 μm. Abbreviations: postnatal month 7, PM7; primary visual cortex, V1.
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trafficking, cell growth and differentiation [7]. As the
temporal and spatial pattern of MHCI expression corre-
lates with synaptogenesis in the primary visual cortex,
we decided to study this further. Enucleation of one eye
before critical stages of visual cortex development
induces significant morphological and physiological
changes in V1 [18,22]. Monocular deprivation, induced
by either unilateral enucleation or by other means (eye--
lid suture or pharmacological blockade of retinal activ-
ity), causes the intact eye to dominate the V1, both
anatomically and physiologically [18]. Dendritic arbors
of the neurons in V1 receiving afferents from the
deprived eye shrink [58]. This shrinkage presumably
reduces the width of ODCs subserving the deprived eye
[18,58,59]. On the other hand, ODCs subserving the
intact eye expand [60-63]. It is known that synaptic
input regulates gene expression in target neurons and
previous gene expression studies have reported major
activity-dependent changes in the expression of numer-
ous genes [64,65]. We used monocular enucleation
(ME) to induce the aforementioned changes in V1 of
the marmoset. Animals were enucleated at one month
and were sacrificed at five months of age [28]. MHCI-
HC gene expression in visual cortices of monocularly
enucleated animals and age-matched controls were com-
pared using qRT-PCR with MHCI-HC PCR primers
designed to recognize the intracellular domain of Caja-
G. Both left and right visual cortices were used from all
animals. In the present study, MHCI-HC transcript
levels were significantly higher in the visual cortices of
enucleated animals, as determined by qRT-PCR (quanti-
tative Real Time Polymerase Chain Reaction, Figure 7).
Also, quantitative in situ hybridization using the Caja-G
probe confirmed the qRT-PCR results revealing a higher
density of silver grains over cells in layer IV of the pri-
mary visual cortex of the enucleated animals (Figure 8A
and 8B).
Neurons with higher MHCI-HC expression receive
afferents from the intact eye
In situ hybridization was not able to shed light as to
where the elevated MHCI-HC transcript levels are loca-
lized, in neurons receiving afferents from the intact or
from the enucleated eye. Hence, in order to localize
MHCI-HC expression in the V1 of the enucleated ani-
mals, we performed immunohistochemistry using the
TP25.99 antibody. Control animals (5 months old) dis-
played a relatively uniform staining pattern throughout
V1 (Figure 9A). In contrast, TP25.99 revealed a patchy
pattern of immunoreactivity in V1 of enucleated animals
(Figure 9Band Additional file 6). To assign the regions
of high and low immunoreactivity to neurons receiving
afferents from either the intact or the enucleated eye,
we stained adjacent sections for a known activity-
marker, a method commonly employed in monocular
deprivation paradigms [66,67]. For this study, we used
c-Fos as a marker of neuronal activity [68,69]. Expres-
sion of both c-Fos and MHCI-HC was uniform, albeit at
a very low level in control animals (Figure 9A and 9B).
Figure 6 MHCI-HC colocalizes with radial glia marker in the subcortical white matter of the occipital lobes.M H C I - H C( g r e e n ;A )i s
localized to vimentin-positive radial glia (red; B and C) in the subcortical white matter (SWM). Higher magnification reveals colocalization
between MHCI-HC and vimentin signals (white arrowheads in D). Scale bar in C: 50 μm; scale bar in D: 25 μm. Abbreviations: postnatal month 1,
PM1; subcortical white matter, SWM.
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enucleation, column-like patches of c-Fos and MHCI-
HC immunoreactivity were visible throughout layer IV
of V1 (Figure 9C and 9D and Additional file 6). Com-
parison of adjacent sections stained for MHCI-HC and
c-Fos showed that the columns with high MHCI-HC
immunoreactivity overlap with regions of high c-Fos
immunoreactivity (Figure 9C and 9D and Additional file
6). Secondary visual cortex (V2) displayed no such col-
umn-like patches, neither in c-Fos nor in MHCI-HC
staining (data not shown). Although the patchy appear-
ance of MHCI-HC immunoreactivity was encompassing
not only layer IV, but also layers II and III, we measured
the optical density profiles only in layer IV since this is
the main recipient layer. In sections from the enucleated
animals, the MHCI-HC optical density profile from the
entire layer IV in V1, measured along its horizontal axis
(Figure 10A), displayed variations in intensity that were
not observed in control animals (Figure 10B). Regions
with high and low immunoreactivity were detected in
these subjects. In contrast, control animals displayed a
relatively weak and uniform staining of all layers (Figure
9A; Figure 10B). As it was previously shown that col-
umns with neurons receiving afferents from the intact
eye are wider and occupy larger regions in V1, we mea-
sured the width of columns exhibiting high and
low MHCI-HC immunoreactivity [61]. A significant
Figure 7 MHCI-HC mRNA expression is upregulated in
response to monocular enucleation. qRT-PCR reveals a significant
difference in MHCI-HC mRNA expression levels in the whole visual
cortices of animals that have undergone monocular enucleation
(ME) and controls. Data are expressed as mean ± SEM (standard
error of the mean) and are representative of three independent
experiments performed with samples isolated from both
hemispheres of N = 3 animals/group. Significant differences
between groups as determined by Student’s two-tailed t-test: *,
p < 0.05 (t = 2.961 df = 10).
Figure 8 Monocular enucleation upregulates MHCI-HC mRNA
in layer IV of the primary visual cortex. A: Numbers of silver
grains per cell reveal elevated levels of MHCI-HC expression in layer
IV of the V1 of enucleated animals (ME). Data are expressed as
mean ± SEM (standard error of the mean), N = 3 animals/group.
Significant differences between groups as determined by Student’s
two-tailed t-test: *, p < 0.05 (t = 3.781, df = 4). B: Examples of
sections from layer IV of the primary visual cortex of a control and
an enucleated animal showing silver grains over cells (circular
counting mask). Scale bar: 20 μm. Abbreviations: Postnatal month 5,
PM5; primary visual cortex, V1.
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exhibiting high and low immunoreactivity, with stronger
MHCI-HC staining intensity localized in the wider col-
umns (Figure 10C). Furthermore, a number of previous
studies have associated the expression of NMDAR1 (N-
methyl D-aspartate receptor subunit 1) with develop-
mental plasticity in the visual cortex [37,61,70]. After
monocular deprivation, hi g h e rl e v e l so fN M D A R 1a r e
present on neurons that still receive visual input and
afferents from the intact eye [37,61,70]. In the present
study, MHCI-HC protein was localized on NMDAR1-
positive neurons in V1 of enucleated animals, which
further supports the notion that MHCI-HC expression
levels are associated with neuronal activity (Additional
file 7). Interestingly, transcript levels of the activity mar-
ker c-Fos [68,69] were also significantly elevated in the
enucleated animals, similar to MHCI-HC levels (Addi-
tional file 8). These results confirm the hypothesis that
the columns with high MHCI-HC immunoreactivity
receive afferents from the intact eye, suggesting that
high expression levels of this gene are associated with
high neuronal activity.
Discussion
Several recent studies have implicated MHCI proteins in
the elimination of excess synapses in the visual system
during distinct phases of cortical development
[12,15,23]. MHCI molecules, as well as the organization
of the visual system, differ between rodents and pri-
mates, including humans [17,24]. We therefore investi-
gated the expression of neuronal MHCI molecules in
the brain of the common marmoset monkey. To the
best of our knowledge, the present study is the first to
characterize the spatio-temporal pattern of MHCI gene
expression in the primary visual cortex during postnatal
development in a nonhuman primate.
Expression and localization of MHCI molecules in V1
It is known that virtually all nucleated cells express
MHCI molecules in form of completely assembled
Figure 9 Primary visual cortex reveals a banded pattern of MHCI-HC and c-Fos immunoreactivity in enucleated animals. A-D: Patches
of stained neurons can be observed in enucleated (C and D), but not in control animals (A and B). These patches are detected with the MHCI
antibody (C) and with the c-Fos antibody (D). Asterisks in C and D denote identical blood vessels. Roman numerals indicate cortical layers.
Abbreviation: primary visual cortex, V1; monocularly enucleated animal, ME. Note: Black horizontal lines in the lower parts of C and D indicate
areas with high MHCI-HC and c-Fos immunoreactivity; white lines point to low immunoreactivity areas.
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Page 12 of 18Figure 10 MHCI-HC is upregulated in primary visual cortex neurons that receive afferents from the intact eye. A: Example of the region
analyzed for optical density measurements (delineated with white, dashed line). Abbreviations: primary visual cortex, V1; monocularly enucleated
animal, ME. B: Optical density profiles recorded from layer IV of the primary visual cortex of a control animal (black dotted line) and two
enucleated animals (red and blue dotted lines). C: Width of MHCI-HC immunoreactive column-like patches showing that the wider columns
display stronger MHCI-HC staining indicating that MHCI-HC levels are elevated in neurons receiving afferents from the intact eye. Difference
between the groups is highly significant as determined by Student’s two tailed t-test: **, p < 0.01 (t = 5.166 df = 4). Data are expressed as mean
± SEM (standard error of the mean), N = 3 animals/group, 12 measurements per animal. Note: Black horizontal lines in (A) and (B) indicate areas
with high MHCI-HC immunoreactivity, while white lines point to low immunoreactivity areas.
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free heavy chains [4,6]. The present study clearly
showed that MHCI molecules are expressed on MAP-2
positive neurons of V1. However, in this and our pre-
vious studies [56,57], we were only able to detect neuro-
nal expression of MHCI heavy chain proteins. In
addition, in situ hybridization and immunohistochemis-
try revealed high expression levels of MHCI-HC
throughout the subcortical white matter (SWM) of the
occipital lobes, consistent with what has previously been
observed in cats [15]. In SWM, MHCI-HC protein colo-
calized with vimentin-positive radial glial cells. These
highly specialized cells are regarded as neuronal precur-
sors and are involved in proper development and migra-
tion of cortical neurons [51]. In primates, these cells are
also GFAP-positive from early prenatal stages, but can
be distinguished from astrocytes on the basis of their
distinct morphology and localization [71]. We did not
detect any vimentin-positive cells in the cortical layers,
and MHCI-HC was not expressed in GFAP-positive cor-
tical astrocytes (Additional file 4), although these astro-
cytes were stained with the antibody that recognized
fully assembled, heterotrimeric form of MHCI (Addi-
tional file 5). These findings further implicate MHCI in
proper development of the visual cortex, although their
potential function in this context remains elusive [72].
As the marmoset MHCI gene cluster is not fully charac-
terized yet, we hope that future studies will shed light
on the exact identity and potential functional differences
between neuronal, radial glial and microglial MHCI.
Previous studies have shown that MHCI proteins may
be localized to both pre- and postsynaptic sites
[14,23,57,73,74]. The MHCI-HC molecules detected
here with confocal microscopy and TP25.99 antibody
seem to be associated with the postsynaptic sites (cell
bodies and dendrites, Figure 5) and they displayed no
obvious preference for excitatory vs inhibitory synapses
(Additional file 3), as has previously been reported [23].
MHCI-HC mRNA and protein expression in the developing
visual cortex
In contrast to the previous studies in rodents and cats
[12,15], we did not detect expression of MHCI-HC in
the LGN at postnatal stages used in this study. It is pos-
sible that MHCI genes are expressed prenatally in the
marmoset LGN, as the segregation of LGN layers in pri-
mates occurs in utero [39,40]. Furthermore, the probe
used here for the detection of MHCI-HC transcripts is
specific for a subset of MHCI molecules, while the
probes used in previous studies were mostly pan-specific
and therefore detected a larger variety of MHCI mole-
cules [15]. Even so, the present data showed that MHCI
genes are strongly expressed throughout all regions of
the visual cortex of the marmoset. In contrast to the in
situ hybridization that revealed a distinct spatio-tem-
poral pattern of MHCI-HC expression, the staining pat-
tern generated with the TP25.99 antibody was rather
uniform throughout all cortical layers and developmen-
tal stages. While the MHCI subset-specific riboprobe
used for in situ h y b r i d i z a t i o nv e r yl i k e l yt a r g e t e do n l ya
few MHCI genes, the antibody we used for histochem-
ical detection of MHCI targets the most conserved,
monomorphic part of these molecules. Hence, the
T P 2 5 . 9 9a n t i b o d yl i k e l yr e c ognized a large number of
MHCI-HC proteins expressed on V1 neurons, including
the ones targeted at the mRNA level by in situ hybridi-
zation riboprobe. As previously mentioned, the common
marmoset MHCI gene cluster is not yet fully character-
ized and so far only two loci have been described, the
classical Caja-G and the non-classical Caja-E [38]. Based
on this (Additional file 2) and our previous studies
[56,57], we believe that the neuronal MHCI-HC
detected in the present study is a classical marmoset
MHCI, Caja-G. Nonetheless, the levels of MHCI-HC
protein expression in the visual cortex correlated well
with the levels of SNAP-25 (synaptosome-associated
protein 25 kDa). This protein is an established synapto-
genesis marker [43,75,76] and the present data on
SNAP-25 protein expression levels confirmed previous
findings that synapse density in the marmoset V1
reaches very high values in the third postnatal month,
followed by a rapid decline due to synapse elminiation
[25,26]. Contrary to our expectations and to the pro-
posed role for MHCI in the elimination of synapses
[12,15,23], MHCI-HC protein expression was at its peak
already in the third postnatal month, together with
SNAP-25 levels, and was in decline in the fifth postnatal
month. This suggests that, as recently proposed [74],
MHCI proteins may exert their function during synapto-
genesis, rather than during refinement and elimination
of synapses.
MHCI expression in the visual cortex is activity dependent
As genetic manipulation of primates is still either una-
vailable or at an early stage [77], we used monocular
deprivation as an alternative model to further clarify the
role of MHCI molecules in the marmoset visual cortex.
Prolonged monocular deprivation induced by various
means (in the order of months) induces morphological
changes in the visual cortex because neurons that
receive input from the intact eye expand their connec-
tions and cortical space at the expense of neurons that
receive afferents from the deprived eye [21,60]. A num-
ber of studies have shown that monocular deprivation
results in the upregulation of growth factors and genes
associated with neuronal degeneration or synaptogenesis
[64,65,78]. In mice, monocular deprivation increases
levels of SNAP-25 and SynCAM (synaptic cell adhesion
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for synaptogenesis [79-81]. Interestingly, MHCI-HC
transcript levels detected in the present study after
monocular enucleation with qRT-PCR and in situ hybri-
dization for classical marmoset MHCI-HC were also
higher in response to monocular enucleation. The levels
of neuronal activity marker c-Fos were also elevated. On
the contrary, GFAP displayed no significant change in
either expression levels or in expression pattern in enu-
cleated animals (Additional file 9). This even further
correlated MHCI-HC levels with neuronal activity, and
not with microglial activation.
We used immunohistochemistry to localize the ele-
vated MHCI-HC levels to neurons receiving afferent
inputs from the intact eye. In V1 of enucleated animals,
both the well-established activity marker c-Fos [68,69]
and MHCI-HC immunostaining revealed a pattern of
column-like patches, where regions of high c-Fos and
high MHCI-HC immunoreactivity overlapped and were
wider than regions with low immunoreactivity. These
changes were visible not only in layer IV, but also in
layers I-III and layer VI, which is not surprising since it
is known that prolonged deprivation causes responses in
neurons in all cortical layers [82]. Previous studies in
marmosets have shown that such patches correspond to
ocular dominance columns. They differ in size in mono-
cularly deprived animals, with wider ODCs receiving
input from the intact eye and showing higher levels of
NMDAR1 [61,70]. Interestingly, MHCI-HC protein
detected in this study also localized to NMDAR1-posi-
tive neurons in the cortex of enucleated animals (Addi-
tional file 7), which is also indicative of MHCI
association with neuronal activity [61,70]. Therefore,
MHCI-HC immunoreactivity in the visual cortex of enu-
cleated animals suggested the upregulation of expression
of this class of genes in neurons receiving input from
the intact eye. As mentioned above, synaptogenesis in
the marmoset visual cortex peaks in the third postnatal
month. Although elimination of synapses and synapto-
genesis may occur within the same time window in the
developing V1 [83], it is interesting to note that MHCI
expression peaks during the synaptogenesis stage. More-
over, the observed upregulation of MHCI levels in
response to monocular enucleation points to a possible
role in synaptogenesis.
Potential interspecies differences in properties of
neuronal MHCI molecules
The so-called classical MHCI molecules detected in
this study are traditionally regarded as having only
immunity-related functions, but they have recently
been implicated in synaptic refinement in the visual
system [23]. Even though our data indicated a potential
interspecies difference in the function of classical
MHCI in the visual system, the very large number of
these genes and the fact that there are no true ortholo-
gues between rodents and primates [17] makes direct
comparisons very difficult. On the other hand, the pos-
sible interspecies differences in function are not sur-
prising. MHCI molecules exhibit a multitude of
functions and may, for example, transmit both activat-
ing and inhibitory signals in the immune system [7,84].
MHCI proteins are also necessary for immunological
synapse formation [85]. In addition to their role in
synaptic refinement and stripping, MHCI molecules
have been implicated in stabilization of certain types of
terminals in the peripheral nervous system of mice
[86]. The exact mechanism and role of MHCI in the
visual cortex is yet to be elucidated, although previous
studies have shown that MHCI may associate with PI-
3, which is known to be a synaptogenic molecule
[8,87]. Another possibility includes the MHCI-present-
ing peptides, as it is known that they reflect the meta-
bolic state of the cell [88]. Given that neuronal MHCI
expression in the visual cortex is activity-regulated,
similar to c-Fos ([15] and this study), this would
enable it to mark or tag neurons or neuronal popula-
tions that display a distinct activity. A recent study
also suggested that neuronal MHCI may be involved in
NMDA-induced internalization of AMPARs (a-amino-
3-hydroxyl-5-methyl-4-isoxazole-propionate receptors,
[89]). AMPARs belong to the group of activity-
regulated molecules involved in developmental plasti-
city in the visual cortex [90,91]. As we were able to
reliably detect only the free heavy chain form of MHCI
proteins on neurons (this study and [56,57]), the sug-
gested link between MHCI and trafficking of AMPARs
is very intriguing considering our current study and
previous studies on MHCI involvement in receptor
trafficking [6,56,57].
Current limitations
As previously mentioned, there are no true orthologues
between MHC class I genes of rodents and primates
[17]. MHC gene cluster shows significant interspecies
variability, as well as a fast evolutionary rate [2,3,17].
This makes drawing parallels between rodent and pri-
mate studies extremely difficult. Furthermore, current
policies on the use of non-human primates in research
are very limiting, which makes functional studies on
non-human primates hard to perform.
It is our hope that the further development of trans-
genic marmoset models [77], more flexible research
policies, as well as detailed characterization of the mar-
moset MHC cluster, will provide future researchers with
the tools to investigate the potential functional differ-
ences between neuronal MHCI molecules in rodents
and primates in more detail.
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Despite the possible interspecies differences in expres-
sion of MHCI molecules in the brain, all studies on this
topic have highlighted yet another important role of
these molecules. MHC genes have been linked to a
number of CNS disorders and the discovery of their
roles in plasticity processes in the brain has shed new
light on their etiology [84,92-94]. Further research is
warranted to elucidate the exact mechanisms of action
of the neuronal MHCI genes and the exact identity of
t h en e u r o n a lM H C Ig e n ep o s s i b l yi n v o l v e di n
synaptogenesis.
Additional material
Additional file 1: All products of the qRT-PCR reactions yielded a
single product. After the qRT-PCR reactions, 3-5 μL of one sample for a
primer pair (Caja-G, c-Fos, GFAP and ACTB) was run on a 2.5% agarose
gel. No template controls (NTC) revealed no product. DNA size marker
(NEB QuickLoad 50 bp) with relevant sizes in bp marked on the left side
of the gel images.
Additional file 2: Caja-G qRT-PCR yielded a single product
corresponding to Caja-G locus only. After the qRT-PCR, the reaction
product was purified using QIAquick PCR Purification Kit (QIAGEN) and
sequenced using the forward primer used for the qRT-PCR reaction (bold
and italics in the Caja-G sequence). The obtained sequence (bolded and
highlighted in grey in the Caja-G sequence) was identified as Caja-G
(alleles Caja-G*1, *3 and *5) using NCBI BLAST tool. Example of pairwise
alignments generated by BLAST, as well as the BLAST hits table are
shown in the lower part of the figure.
Additional file 3: MHCI-HC protein is localized on both excitatory
and inhibitory synapses in the marmoset primary visual cortex.
Upper row: MHCI-HC (green; A) partially colocalizes with inhibitory
synapse marker gephyrin (red, B; white arrowheads, C). Lower row:
MHCI-HC (green; D) partially colocalizes with the excitatory synapse
marker SAP102 (red, D; white arrowheads, E). Scale bar for all images: 20
μm.
Additional file 4: MHCI-HC protein is not detected on glial cells in
the cortex. Upper panel: vimentin-positive cells and processes (green)
in subcortical white matter of the occipital lobes are also GFAP-positive
(red; white arrowheads in merged image). Scale bar: 50 μm. Lower
panel: MHCI-HC positive cells (green) in subcortical white matter of the
occipital lobes are also GFAP-positive (red; white arrowheads in merged
image). Abbreviations: SWM, subcortical white matter; PM1, postnatal
month 1. Scale bar: 50 μm. A) Upper panel: vimentin immunoreactivity
cannot be detected in the cortex, as opposed to GFAP-immunoreactivity
(red). Scale bar: 30 μm. Lower panel: In the layer IV of the visual cortex,
MHCI-HC signal (green) is not overlapping with GFAP-positive astrocytes
(red; merged image). Scale bar: 30 μm.
Additional file 5: Microglial MHCI molecules are heterotrimeric. Left
panel: Immunohistochemistry with W6/32 antibody specific for the
heterotrimeric form of MHCI molecules revealed staining of microglial
cells (arrows) and processes in the marmoset cortex. Middle panel: Q1/
28 antibody, which recognizes the free heavy chain form of MHCI
molecules, labelled neurons in the same region (arrowheads), similar to
what can be detected with TP25.99 antibody (right panel, arrowheads).
Scale bar for all images: 150 μm.
Additional file 6: Primary visual cortex of all enucleated animals
reveals banded pattern of MHCI-HC and c-Fos immunoreactivity.
Black horizontal lines in the lower parts of the images indicate areas with
high MHCI-HC and c-Fos immunoreactivity; white lines point to low
immunoreactivity areas. Animals ME1 and 2 are siblings. Asterisks denote
identical blood vessels. Note: Middle panel, MHCI-HC staining: black
region in the right part of the image is an artefact. Note: Black
horizontal lines in upper panel in (B) indicate areas with high c-Fos
immunoreactivity, while white lines point to low immunoreactivity areas.
Scale bar: 0.5 mm.
Additional file 7: MHCI-HC protein is localized on NMDAR1-positive
neurons in the visual cortex of enucleated animals. MHCI-HC (A) is
present on NMDAR1-positive neurons in the primary visual cortex of
enucleated animals (B, white arrowheads in C). Higher magnification
reveals MHCI-HC clusters (D) overlapping with NMDAR1 clusters (E, white
arrowheads in F). Scale bar in C: 50 μm; scale bar in D: 25 μm.
Abbreviations: ME, monocularly enucleated animals; V1, primary visual
cortex.
Additional file 8: c-Fos mRNA expression is upregulated in response
to monocular enucleation. qRT-PCR reveals a significant difference in c-
Fos mRNA expression levels in the whole visual cortices of animals that
have undergone monocular enucleation (ME) and controls. Data are
expressed as mean ± SEM (standard error of the mean) and are
representative of three independent experiments performed with
samples isolated from both hemispheres of N = 3 animals/group.
Significant differences between groups as determined by Student’s two-
tailed t-test: *, p < 0.05 (t = 2.875 df = 10).
Additional file 9: Effects of monocular enucleation on the
expression of GFAP mRNA and protein expression. A) Enucleation
has no significant effect on the levels of GFAP mRNA in the visual
cortex as determined with qRT-PCR. Abbreviations: ME, monocularly
enucleated animals. Data are expressed as mean ± SEM (standard error
of the mean) from 2 independent experiments, N = 3 animals/group (ns,
not significant; Student’s two-tailed t-test). B) Enucleation has no
visible effect of GFAP immunoreactivity in the visual cortex of
enucleated animals. Adjacent sections were processed for c-Fos and
GFAP immunostaining. While c-Fos revealed patchy immunoreactivity in
the visual cortex of enucleated animals (upper panel), GFAP revealed
uniform staining pattern (lower panel). Abbreviations: ME, monocularly
enucleated animals; V1, primary visual cortex.
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